Top

BMC Infectious Diseases

Published in:

Open Access 01-12-2019 | Systemic Lupus Erythematosus | Case report

Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature

Authors: Shayuan Shao, Xin Guo, Penghao Guo, Yingpeng Cui, Yili Chen

Published in: BMC Infectious Diseases | Issue 1/2019

Abstract

Background

Roseomonas mucosa, as a Gram-negative coccobacilli, is an opportunistic pathogen that has rarely been reported in human infections. Here we describe a case of bacteremia in an infective endocarditis patient with systemic lupus erythematosus (SLE).

Case presentations

A 44-year-old female patient with SLE suffered bacteremia caused by Roseomonas mucosa complicated with infective endocarditis (IE). The patient started on treatment with piperacillin-tazobactam and levofloxacin against Roseomonas mucosa, which was switched after 4 days to meropenem and amikacin for an additional 2 weeks. She had a favorable outcome with a 6-week course of intravenous antibiotic therapy.

Discussion and conclusions

Roseomonas mucosa is rarely reported in IE patients; therefore, we report the case in order to improve our ability to identify this pathogen and expand the range of known bacterial causes of infective endocarditis.

Romano-Bertrand S, Bourdier A, Aujoulat F, Michon AL, Masnou A, Parer S, Marchandin H, Jumas-Bilak E. Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental. Clin Microbiol Infect. 2016;22(8):731–7.CrossRef

Kim YK, Moon JS, Song KE, Lee W. Two cases of bacteremia due to Roseomonas mucosa. Ann Lab Med. 2016;36(4):367.CrossRef

Rihs JD, Brenner DJ, Weaver RE, Steigerwalt AG, Hollis DG, Yu VL. Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol. 1993;31(12):3275–83.PubMedPubMedCentral

Han XY, Pham AS, Tarrand JJ, Rolston KV, Helsel LO, Levett PN. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsprosea subsp nov. Am J Clin Pathol. 2003;120(2):256–64.CrossRef

Matsukuma Y, Sugawara K, Shimano S, Yamada S, Tsuruya K, Kitazono T, Higashi H. A case of bacterial peritonitis caused by Roseomonas mucosa in a patient undergoing continuous ambulatory peritoneal dialysis. CEN Case Rep. 2014;3(2):127–31.CrossRef

Diesendorf N, Köhler S, Geißdörfer W, Grobecker-Karl T, Karl M, Burkovski A. Characterisation of Roseomonas mucosa isolated from the root canal of an infected tooth. BMC Res Notes. 2017;10(1):212.CrossRef

Kim K, Hur J, Jo W, Hong J, Cho O, Kang DH, Kim S, Bae I. Infectious spondylitis with bacteremia caused by Roseomonas mucosa in an immunocompetent patient. Infect Chemother. 2015;47(3):194.CrossRef

Boyd MA, Laurens MB, Fiorella PD, Mendley SR. Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis. J Clin Microbiol. 2012;50(11):3801–4.CrossRef

Bard JD, Deville JG, Summanen PH, Lewinski MA. Roseomonas mucosa isolated from bloodstream of pediatric patient. J Clin Microbiol. 2010;48(8):3027–9.CrossRef

10.

Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059.CrossRef

11.

Libman ESB. A hitherto undescribed form of valvular and mural endocarditis; 1924.CrossRef

12.

Afonso L, Kottam A, Reddy V, Penumetcha A. Echocardiography in infective endocarditis: state of the art. Curr Cardiol Rep. 2017;19(12):127.CrossRef

13.

Duval X, Delahaye F, Alla F, Tattevin P, Obadia J, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. J Am Coll Cardiol. 2012;59(22):1968–76.CrossRef

14.

Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D, Nacinovich F, Tattevin P, Fernandez-Hidalgo N, Dickerman S, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829–35.CrossRef

15.

Falcone M, Tiseo G, Durante-Mangoni E, Ravasio V, Barbaro F, Ursi MP, Pasticci MB, Bassetti M, Grossi P, Venditti M, et al. Risk factors and outcomes of endocarditis due to non-HACEK gram-negative bacilli: data from the prospective multicenter Italian endocarditis study cohort. Antimicrob Agents Chemother. 2018;62(4). https://doi.org/10.1128/AAC.02208-17.

16.

Ece G, Ruksen M, Akay A. Case report: cranioplasty infection due to Roseomonas gilardii at a university hospital in Turkey. Pan Afr Med J. 2013;14:162.CrossRef

17.

Michon A, Saumet L, Bourdier A, Haouy S, Sirvent N, Marchandin H. Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2014;36(3):e165–8.CrossRef

18.

Wang C, Lai C, Tan C, Huang Y, Chung K, Lee M, Hwang K, Hsueh P. Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates. Diagn Microbiol Infect Dis. 2012;72(3):199–203.CrossRef

19.

Tsai S, Chen C, Shu K, Wu M. Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review. Intern Med. 2012;51(13):1721–4.CrossRef

20.

Al-Anazi KA, AlHashmi H, Abdalhamid B, AlSelwi W, AlSayegh M, Alzayed A, Alshibani Z, AlGarni A, Al-Ghanem A, Hassan H, et al. Roseomonas bacteremia in a recipient of an allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15(4):E144–7.CrossRef

21.

Kaore N, Khan Z, Aher A, Ramnani VK. Community acquired Roseomonas infection in a pre-existing tubercular lung lesion. Lung India. 2014;31(3):289.CrossRef

Title: Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature
Authors: Shayuan Shao
Xin Guo
Penghao Guo
Yingpeng Cui
Yili Chen
Publication date: 01-12-2019
Publisher: BioMed Central
Keywords: Systemic Lupus Erythematosus
Levofloxacin
Transthoracic Echocardiography
Amikacin
Antibiotic
Piperacillin
Meropenem
Endocarditis
Published in: BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-019-3774-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature

Abstract

Background

Case presentations

Discussion and conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentations

Discussion and conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Correction to: Seasonal dynamics of influenza in Brazil: the latitude effect

Diagnostic tools used in the evaluation of acute febrile illness in South India: a scoping review

Susceptibility for varicella and factors associated with immunity among pregnant women in a tertiary care hospital in Sri Lanka- a cross-sectional study

Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India

The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis

Maternal hepatitis B surface antigen carrier status increased the incidence of gestational diabetes mellitus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page